Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Bridgebio Pharma Inc
Today
Create an eToro account to buy BBIO stock on a secure, user-friendly, multi-asset trading platform.
Buy Bridgebio Pharma Inc
Buy Bridgebio Pharma Inc
Bridgebio Pharma Inc BBIO
Stocks-BBIO-Bridgebio Pharma Inc

Bridgebio Pharma Inc BBIO

$36.082.29(6.78%)(1D)

BBIO Stock Price Chart

33.15%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Bridgebio Pharma Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Bridgebio Pharma Inc share price today is 36.08, reflecting a 6.78% change over the last 24 hours and 1.72% over the past week. The current market capitalization of BBIO is 6.82B with an average volume in the last three months of 2.3M. The stock has a P/E ratio of -14.96 and a dividend yield of 0%. With the stock’s beta sitting at 1.98
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$6.82B

Day’s Range
i
Shows the high and low prices of the day.
27.26 - 36.19

52W Range
i
Shows the high and low prices of the last year.
16.59 - 44.08

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.3M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-14.96

Revenue
i
The total income generated by this company’s goods and services last year.
$217.77M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$36.08

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.41

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.98

What Is Bridgebio Pharma Inc?
BridgeBio Pharma is a healthcare firm based in the Californian city of Palo Alto. Founded in 2015, it works within the US to create treatments for genetic diseases. BridgeBio stock is traded on the NASDAQ GS as BCRX. Want more BCRX price info? Track this ticker on eToro today.

How can I buy Bridgebio Pharma Inc stocks?

To purchase Bridgebio Pharma Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Bridgebio Pharma Inc (BBIO) page and place an order to buy Bridgebio Pharma Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Bridgebio Pharma Inc
Invest in Bridgebio Pharma Inc
Today
Create an eToro account to buy BBIO stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of BBIO is 36.08.
The average price target for Bridgebio Pharma Inc is 36.08. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Bridgebio Pharma Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Bridgebio Pharma Inc is 6.82B
Scroll to top